Mary E. Klotman, MD, Executive Vice President for Health Affairs, Duke University; Dean, Duke University School of Medicine, and Chief Academic Officer, Duke Health and Craig Albanese, MD, MBA, Chief Executive Officer, Duke University Health System detail how they're working together to build deeper alignment between Duke’s clinical, academic, research and global health missions, and establish a unified system in which each part enhances the other.
The School of Medicine kicked off a new restorative justice pilot program with participants from across School of Medicine departments and units.
Everardo Macias's quest to find innovative treatments for prostate cancer mirrors his own incredible journey – from a migrant farm worker to a groundbreaking scientist.
The School of Medicine’s new employee resource group ¡DALHE! Kicked off its inaugural event recognizing Hispanic Heritage Month on Friday, October 6.
Immunologists identify a pivotal protein in the progression of MS. Could blocking it be the future of treatment?
A host of luminaries, including seven Nobel Laureates, two former chancellors, and scores of Robert J. Lefkowitz’s former trainees gather to celebrate his 50 years at Duke.
Study Identifies Molecularly Unique Form of Triple-negative Breast Cancer in Younger African American Women
Research finds younger African American women with triple-negative breast cancer may have a molecularly distinct form of the disease that makes it more aggressive.
When Felicia Pagliuca arrived at Duke as a first-year undergraduate student from Asheville, she was only 16, but she was already fascinated by biology and physics. She knew she wanted to do scientific research “someday.”
Synthetic chemicals that mimic menthol’s cooling sensations are being added to newly introduced “non-menthol” cigarettes in states that have banned the additive, according to a new study from Duke Health.